Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Mar;31(3):438–442. doi: 10.1128/aac.31.3.438

Erythromycin-resistant Campylobacter infections in Thailand.

D N Taylor, M J Blaser, P Echeverria, C Pitarangsi, L Bodhidatta, W L Wang
PMCID: PMC174747  PMID: 3579261

Abstract

Erythromycin therapy was compared with no treatment in a prospective trial of acute diarrheal disease among 100 infants in an orphanage in Bangkok. Within 24 h of the onset of diarrhea, 50 children received erythromycin ethylsuccinate (40 mg/kg per day) in four divided doses for 5 days. Campylobacter jejuni isolated from 31, Campylobacter coli isolated from 21, and Shigella spp. isolated from 21 of 100 children were the most commonly recognized pathogens; use of a sensitive, nonselective method substantially increased Campylobacter isolation. Treatment with erythromycin had no effect on the duration of diarrhea caused by Campylobacter spp., Shigella spp., or other agents; 37% of the treatment group and 35% of the control group had diarrhea for 1 week. Of 23 Campylobacter strains isolated from the treatment group before treatment, 15 (65%) were resistant (MIC, greater than or equal to 8 micrograms/ml) to erythromycin. Among orphanage-acquired strains, 53% of 43 C. jejuni strains and 91% of 23 C. coli strains were resistant to erythromycin compared with 11% of 114 C. jejuni strains and 46% of 35 C. coli strains that were community acquired. Erythromycin resistance is common among Campylobacter strains in Bangkok, especially in an institutional setting, which may account for the lack of efficacy of erythromycin for treatment of acute diarrheal illnesses.

Full text

PDF
438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders B. J., Lauer B. A., Paisley J. W., Reller L. B. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet. 1982 Jan 16;1(8264):131–132. doi: 10.1016/s0140-6736(82)90380-4. [DOI] [PubMed] [Google Scholar]
  2. Andremont A., Tancrede C. Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin. Ann Microbiol (Paris) 1981 Nov-Dec;132 B(3):419–427. [PubMed] [Google Scholar]
  3. Blaser M. J., Berkowitz I. D., LaForce F. M., Cravens J., Reller L. B., Wang W. L. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med. 1979 Aug;91(2):179–185. doi: 10.7326/0003-4819-91-2-179. [DOI] [PubMed] [Google Scholar]
  4. Blaser M. J., Glass R. I., Huq M. I., Stoll B., Kibriya G. M., Alim A. R. Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol. 1980 Dec;12(6):744–747. doi: 10.1128/jcm.12.6.744-747.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blaser M. J., Reller L. B. Campylobacter enteritis. N Engl J Med. 1981 Dec 10;305(24):1444–1452. doi: 10.1056/NEJM198112103052404. [DOI] [PubMed] [Google Scholar]
  6. Bokkenheuser V. D., Richardson N. J., Bryner J. H., Roux D. J., Schutte A. B., Koornhof H. J., Freiman I., Hartman E. Detection of enteric campylobacteriosis in children. J Clin Microbiol. 1979 Feb;9(2):227–232. doi: 10.1128/jcm.9.2.227-232.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doyle M. P., Roman D. J. Recovery of Campylobacter jejuni and Campylobacter coli from inoculated foods by selective enrichment. Appl Environ Microbiol. 1982 Jun;43(6):1343–1353. doi: 10.1128/aem.43.6.1343-1353.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Echeverria P., Seriwatana J., Taylor D. N., Yanggratoke S., Tirapat C. A comparative study of enterotoxigenic Escherichia coli, Shigella, Aeromonas, and Vibrio as etiologies of diarrhea in northeastern Thailand. Am J Trop Med Hyg. 1985 May;34(3):547–554. doi: 10.4269/ajtmh.1985.34.547. [DOI] [PubMed] [Google Scholar]
  9. Elharrif Z., Mégraud F., Marchand A. M. Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother. 1985 Nov;28(5):695–697. doi: 10.1128/aac.28.5.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greenberg R. N., Pearson R. D., Innes D. J., Sauer K. T., Halterman L. D., Guerrant R. L. Susceptibility of Shigella species to erythromycin. Antimicrob Agents Chemother. 1982 Feb;21(2):347–348. doi: 10.1128/aac.21.2.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karmali M. A., Fleming P. C. Campylobacter enteritis in children. J Pediatr. 1979 Apr;94(4):527–533. doi: 10.1016/s0022-3476(79)80004-9. [DOI] [PubMed] [Google Scholar]
  12. Mandal B. K., Ellis M. E., Dunbar E. M., Whale K. Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection. J Antimicrob Chemother. 1984 Jun;13(6):619–623. doi: 10.1093/jac/13.6.619. [DOI] [PubMed] [Google Scholar]
  13. Murray B. E., Alvarado T., Kim K. H., Vorachit M., Jayanetra P., Levine M. M., Prenzel I., Fling M., Elwell L., McCracken G. H. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis. 1985 Dec;152(6):1107–1113. doi: 10.1093/infdis/152.6.1107. [DOI] [PubMed] [Google Scholar]
  14. Pai C. H., Gillis F., Tuomanen E., Marks M. I. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child. 1983 Mar;137(3):286–288. doi: 10.1001/archpedi.1983.02140290072019. [DOI] [PubMed] [Google Scholar]
  15. Pitkanen T., Pettersson T., Pomka A., Kosunen T. U. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis. 1982 Jan;145(1):128–128. doi: 10.1093/infdis/145.1.128. [DOI] [PubMed] [Google Scholar]
  16. Rajan D. P., Mathan V. I. Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. J Clin Microbiol. 1982 May;15(5):749–751. doi: 10.1128/jcm.15.5.749-751.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richardson N. J., Koornhof H. J., Bokkenheuser V. D. Long-term infections with Campylobacter fetus subsp. jejuni. J Clin Microbiol. 1981 May;13(5):846–849. doi: 10.1128/jcm.13.5.846-849.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robins-Browne R. M., Coovadia H. M., Bodasing M. N., Mackenjee M. K. Treatment of acute nonspecific gastroenteritis of infants and young children with erythromycin. Am J Trop Med Hyg. 1983 Jul;32(4):886–890. doi: 10.4269/ajtmh.1983.32.886. [DOI] [PubMed] [Google Scholar]
  19. Robins-Browne R. M., Mackenjee M. K., Bodasing M. N., Coovadia H. M. Treatment of Campylobacter-associated enteritis with erythromycin. Am J Dis Child. 1983 Mar;137(3):282–285. doi: 10.1001/archpedi.1983.02140290068018. [DOI] [PubMed] [Google Scholar]
  20. Salazar-Lindo E., Sack R. B., Chea-Woo E., Kay B. A., Piscoya Z. A., Leon-Barua R., Yi A. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr. 1986 Aug;109(2):355–360. doi: 10.1016/s0022-3476(86)80404-8. [DOI] [PubMed] [Google Scholar]
  21. Steele T. W., McDermott S. N. The use of membrane filters applied directly to the surface of agar plates for the isolation of Campylobacter jejuni from feces. Pathology. 1984 Jul;16(3):263–265. doi: 10.3109/00313028409068535. [DOI] [PubMed] [Google Scholar]
  22. Stoll B. J., Glass R. I., Banu H., Huq M. I., Khan M. U., Ahmed M. Value of stool examination in patients with diarrhoea. Br Med J (Clin Res Ed) 1983 Jun 25;286(6383):2037–2040. doi: 10.1136/bmj.286.6383.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Taylor D. E., De Grandis S. A., Karmali M. A., Fleming P. C. Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother. 1981 May;19(5):831–835. doi: 10.1128/aac.19.5.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taylor D. N., Echeverria P., Hanchalay S., Pitarangsi C., Slootmans L., Piot P. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand. J Clin Microbiol. 1985 Mar;21(3):442–444. doi: 10.1128/jcm.21.3.442-444.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wang W. L., Reller L. B., Blaser M. J. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1984 Sep;26(3):351–353. doi: 10.1128/aac.26.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. de Zoysa I., Feachem R. G. Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ. 1985;63(2):295–315. [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES